TTM
61.8%
YoY change
−0.45pp
Trough year (2006)
-405.1%
Peak year (2015)
69.3%
Latest annual
60.0%
Gross Margin history chart for DexCom (DXCM) from 2006 to 2025
Latest: 60.0%
Gross Margin change chart for DexCom (DXCM) from 2006 to 2025
Latest: −0.45pp
Gross Margin history table for DexCom (DXCM) from 2006 to 2025
| 2025 | 60.0% | -0.45pp | ||
| 2024 | 60.5% | -2.73pp | ||
| 2023 | 63.2% | -1.53pp | ||
| 2022 | 64.7% | -3.92pp | ||
| 2021 | 68.6% | +2.19pp | ||
| 2020 | 66.4% | +3.33pp | ||
| 2019 | 63.1% | -1.25pp | ||
| 2018 | 64.4% | -4.13pp | ||
| 2017 | 68.5% | +2.49pp | ||
| 2016 | 66.0% | -3.25pp | ||
| 2015 | 69.3% | +1.24pp | ||
| 2014 | 68.0% | +5.45pp | ||
| 2013 | 62.6% | +15.92pp | ||
| 2012 | 46.6% | -0.35pp | ||
| 2011 | 47.0% | +9.07pp | ||
| 2010 | 37.9% | +25.59pp | ||
| 2009 | 12.3% | +68.53pp | ||
| 2008 | -56.2% | +119.05pp | ||
| 2007 | -175.3% | +229.82pp | ||
| 2006 | -405.1% | — |
- 202560.0%-0.45pp
- 202460.5%-2.73pp
- 202363.2%-1.53pp
- 202264.7%-3.92pp
- 202168.6%+2.19pp
- 202066.4%+3.33pp
- 201963.1%-1.25pp
- 201864.4%-4.13pp
- 201768.5%+2.49pp
- 201666.0%-3.25pp
- 201569.3%+1.24pp
- 201468.0%+5.45pp
- 201362.6%+15.92pp
- 201246.6%-0.35pp
- 201147.0%+9.07pp
- 201037.9%+25.59pp
- 200912.3%+68.53pp
- 2008-56.2%+119.05pp
- 2007-175.3%+229.82pp
- 2006-405.1%—
Gross Margin values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's latest reported gross margin is 61.8%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of DexCom (DXCM) gross margin is 60.01% – contracted 0.4 percentage points year-over-year.
2015 marks the peak gross margin at 69.25%, with the historical low of -405.07% recorded in 2006.
DexCom Gross Margin by Year
DexCom Gross Margin 2025: 60.0%
DexCom posted gross margin of 60.01% in 2025, contracted 0.4 percentage points from 2024.
DexCom Gross Margin 2024: 60.5%
In 2024, DexCom reported gross margin of 60.46%, contracted 2.7 percentage points from 2023.
DexCom Gross Margin 2023: 63.2%
DexCom gross margin in 2023 was 63.19%, contracted 1.5 percentage points from 2022.
DexCom Gross Margin 2022: 64.7%
2022's gross margin for DexCom came in at 64.72%, contracted 3.9 percentage points from 2021.
DexCom Gross Margin 2021: 68.6%
DexCom gross margin in 2021 was 68.63%.
See more financial history for DexCom (DXCM).
Sector peers by Gross Margin
Healthcare peers of DexCom (DXCM), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation